Status:
WITHDRAWN
The Use of L-Carnitine And CoQ10 Supplements In the Treatment of Cyclic Vomiting Syndrome (CVS)
Lead Sponsor:
Medical College of Wisconsin
Collaborating Sponsors:
Children's Hospital Los Angeles
Conditions:
Cyclic Vomiting Syndrome
Eligibility:
All Genders
Brief Summary
This is a study with the principle goal being to learn about the use of L-Carnitine and CoQ10, two vitamin supplements that are currently being used to treat Cyclic Vomiting Syndrome, largely initiate...
Eligibility Criteria
Inclusion
- 3 discrete episodes of vomiting
- normal health between episodes
- stereotypical clinical pattern
- no abnormal test results to account for vomiting (see exclusion criteria)
Exclusion
- abnormal UGI with small bowel follow-through revealing an anatomic anomaly, inflammatory or obstructive
- Significantly abnormal endoscopic biopsies (moderate to severe esophagitis, H. pylori)
- Abnormal abdominal ultrasound revealing hydronephrosis, cholelithiasis, pancreatitis
- Positive screening for endocrine disorder (diabetic ketoacidosis, Addison's)
- Positive screening for inborn errors of metabolism (hypoglycemia, lactic acidosis, hyperammonemia, organic acidemia, amino aciduria, elevated beta-ALA, porphobilinogen)
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00728104
Start Date
October 1 2007
End Date
January 1 2017
Last Update
February 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Wisconsin
Milwaukee, Wisconsin, United States, 53226